Results 121 to 130 of about 1,042 (177)

Nemolizumab (Nemluvio®) for prurigo nodularis

Trends in Pharmacological Sciences
Svenja Royeck, Sonja Ständer
openaire   +1 more source

Successful Nemolizumab Treatment of Refractory Acquired Reactive Perforating Collagenosis in a Diabetic Patient. [PDF]

Cureus
Oikawa A, Muramatsu K, Watanabe K, Shiiya C, Ujiie H.   +4 more
europepmc   +1 more source

Pregabalin as a Potential Adjunct in the Management of Pruritus in Prurigo Nodularis: A Case Report. [PDF]

Cureus
Mima Y, Yamamoto M, Iozumi K.
europepmc   +1 more source

IL-31/33 Axis in Atopic Dermatitis. [PDF]

Int J Mol Sci
Łacwik J, Kraik K, Laska J, Tota M, Sędek Ł, Gomułka K.   +5 more
europepmc   +1 more source

Bridging the cost divide: comparing veterinary and human dermatologic drug pricing in the US. [PDF]

Proc (Bayl Univ Med Cent)
Dowdle TS, Schmidt M, Remmert N, Munoz A.   +3 more
europepmc   +1 more source

Effectiveness of Nemolizumab in Improving Dialysis-Associated Pruritus Refractory to Difelikefalin: A Case Report. [PDF]

Cureus
Mima Y, Yamamoto M, Iozumi K.
europepmc   +1 more source

Chronic Prurigo: Current Knowledge, Treatment Strategies, Future Perspectives, and Unmet Needs. [PDF]

Acta Derm Venereol
Figueras I, Serra-Baldrich E, Ständer S.   +2 more
europepmc   +1 more source

Effectiveness of Nemolizumab for Refractory Pruritus in a Pediatric Patient With Atopic Dermatitis After Biliary Atresia Surgery. [PDF]

Cureus
Masukane S, Taketani T.
europepmc   +1 more source

Patients' Experiences of Atopic Dermatitis and Nemolizumab Treatment: An In-Trial Interview Study Embedded in a Phase 3 Clinical Trial (ARCADIA). [PDF]

Patient
Silverberg JI, Filipenko D, Dias Barbosa C, Rodriguez D, Chambenoit O, Jack K, Piketty C, Subramanian R, Puelles J.   +8 more
europepmc   +1 more source

Beyond the blockade: unmet needs in systemic targeted atopic dermatitis therapy. [PDF]

Front Immunol
Zhang L, Peng G, Wang M, Niyonsaba F, Gao X.   +4 more
europepmc   +1 more source